Layer‐by‐layer assembled PLGA nanoparticles carrying miR‐34a cargo inhibit the proliferation and cell cycle progression of triple‐negative breast cancer cells

Layer-by-Layer Assembled Gold Nanoshells for the Intracellular Delivery of miR-34a

(2018) Ritu Goyal et al.   Cellular and Molecular Bioengineering

Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin

(2018) Touko Inao et al.   Oncotarget

Layer-by-layer siRNA/poly(L-lysine) Multilayers on Polydopamine-coated Surface for Efficient Cell Adhesion and Gene Silencing

(2018) Cheol Am Hong et al.   Scientific Reports

Spherical Nucleic Acid Architecture Can Improve the Efficacy of Polycation-Mediated siRNA Delivery

(2018) Jilian R. Melamed et al.   Molecular Therapy-Nucleic Acids

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy

(2018) Marilina García-Aranda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

(2017) Rajesha Rupaimoole et al.   NATURE REVIEWS DRUG DISCOVERY

Targeted inhibition of Notch1 gene enhances the killing effects of paclitaxel on triple negative breast cancer cells

(2017) Yu-Fu Zhou et al.   Asian Pacific Journal of Tropical Medicine

MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells

(2017) Malav Trivedi et al.   Scientific Reports

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

(2016) Jung Soo Suk et al.   ADVANCED DRUG DELIVERY REVIEWS

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

(2016) Muhammad S. Beg et al.   INVESTIGATIONAL NEW DRUGS

Application of biodegradable dendrigraft poly-l-lysine to a small interfering RNA delivery system

(2016) Yukinobu Kodama et al.   JOURNAL OF DRUG TARGETING

In vivo delivery of miRNAs for cancer therapy: Challenges and strategies

(2015) Yunching Chen et al.   ADVANCED DRUG DELIVERY REVIEWS

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer

(2015) B. D. Adams et al.   CANCER RESEARCH

FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance

(2015) Gabriela Nestal de Moraes et al.   CELLULAR SIGNALLING

Nanoparticle–blood interactions: the implications on solid tumour targeting

(2015) James Lazarovits et al.   CHEMICAL COMMUNICATIONS

CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo

(2015) Nicole Mende et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Influence of pH and Surface Chemistry on Poly(l-lysine) Adsorption onto Solid Supports Investigated by Quartz Crystal Microbalance with Dissipation Monitoring

(2015) Jae-Hyeok Choi et al.   JOURNAL OF PHYSICAL CHEMISTRY B

Principles of nanoparticle design for overcoming biological barriers to drug delivery

(2015) Elvin Blanco et al.   NATURE BIOTECHNOLOGY

Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma

(2015) Donato Cosco et al.   Scientific Reports

microRNA-34a as a Therapeutic Agent against Human Cancer

(2015) Yoshimasa Saito et al.   Journal of Clinical Medicine

miR-34: from bench to bedside

(2015) Massimiliano Agostini et al.   Oncotarget

Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance

(2014) E. Y. Park et al.   CANCER RESEARCH

Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer

(2014) C. L. Daige et al.   MOLECULAR CANCER THERAPEUTICS

Mir-34: A New Weapon Against Cancer?

(2014) Gabriella Misso et al.   Molecular Therapy-Nucleic Acids

Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment

(2013) Zhou J. Deng et al.   ACS Nano

Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology

(2013) Stefan Tenzer et al.   Nature Nanotechnology

The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

(2012) Alexandre Albanese et al.   Annual Review of Biomedical Engineering

MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1

(2012) Xiu-juan Li et al.   ARCHIVES OF MEDICAL RESEARCH

Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up

(2012) L. Malorni et al.   BREAST CANCER RESEARCH AND TREATMENT

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1

(2012) Laisheng Li et al.   CLINICAL AND EXPERIMENTAL MEDICINE

MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1

(2012) S Yang et al.   ONCOGENE

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas

(2012) Wen-Hung Kuo et al.   PLoS One

Occurrence, Biosynthesis, Biodegradation, and Industrial and Medical Applications of a Naturally Occurring ε-Poly-L-lysine

(2011) Yoshimitsu HAMANO   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles

(2011) Rochelle R. Arvizo et al.   PLoS One

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier

(2011) Hirenkumar K. Makadia et al.   Polymers

MicroRNA therapeutics: principles, expectations, and challenges

(2011) Rajesha Rupaimoole et al.   Chinese Journal of Cancer

MicroRNA: Biogenesis, Function and Role in Cancer

(2010) Leigh-Ann MacFarlane et al.   CURRENT GENOMICS

Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy

(2010) Yunching Chen et al.   MOLECULAR THERAPY

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer

(2009) Elena Gallardo et al.   CARCINOGENESIS

Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

(2009) Farrah Kassam et al.   Clinical Breast Cancer

Current advances in research and clinical applications of PLGA-based nanotechnology

(2009) Jian-Ming Lü et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Layer-by-Layer Assembled Gold Nanoparticles for siRNA Delivery

(2009) Asmaa Elbakry et al.   NANO LETTERS

Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells

(2008) Jenilyn J. Virrey et al.   AMERICAN JOURNAL OF PATHOLOGY

Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles

(2008) Jaspreet K. Vasir et al.   BIOMATERIALS

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest

(2008) Fang Sun et al.   FEBS LETTERS

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY

Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

(2008) Frank Alexis et al.   MOLECULAR PHARMACEUTICS

Efficient delivery of siRNA using dendritic poly(l-lysine) for loss-of-function analysis

(2007) Yusuke Inoue et al.   JOURNAL OF CONTROLLED RELEASE